| Place of Origin: | China |
|---|---|
| Brand Name: | HNB |
| Certification: | ISO, SGS |
| Model Number: | Orlistat |
| Minimum Order Quantity: | 1KG |
| Price: | Negotiable |
| Packaging Details: | Carton Box or Drum |
| Delivery Time: | Usually7-10days |
| Payment Terms: | L/C, D/P, D/A, T/T, , MoneyGram |
| Supply Ability: | 5000kg/Month |
| CAS: | 96829-58-2 | Mf: | C29h53no5 |
|---|---|---|---|
| MW: | 495.73 | Assay: | HPLC99% |
| Density: | 1.0±0.1 G/cm3 | Certificate: | GMP/ISO9001 |
| High Light: | Weight Losing Orlistat Powder,CAS 96829-58-2 Weight Losing Raw Material,API Orlistat Powder |
||
CAS 96829-58-2 API Orlistat 99% powder Weight Loss
| Product Name | Orlistat |
| Assay | 99% |
| Apprearance | White crystallie powder |
| Package | 1kg/carton; 25kg/drum |
| Payment | Alipay; ; TT |
| Shipment | DHL; FedEx, EMS; Air; Sea |
| Standard | USP/EP/CP/BP |
| Storage | Sealed in dark and dry place |
| Shelf Life | 2 Years |
The Introductction of Orlistat
Orlistat belongs to the lipase inhibitor class of weight loss drugs, which are hydrated derivatives of lipostatin that reduce the absorption of food fat, resulting in weight loss. This product has potent and selective inhibition of gastric lipase and pancreatic lipase, has no effect on other digestive enzymes (amylase, trypsin, chymase) and phospholipase, and does not affect carbohydrate, protein and phospholipid absorption. The drug is not absorbed by the gastrointestinal tract, and the inhibition of lipase is reversible.
The Function of Orlistat
Combined with micro low-calorie diet for obese and overweight participants including those already obesity-related risk factors of patients with long-term treatment. With long-term weight control (weight loss, maintain weight rebound and prevention) curative effect.
Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity. It is marketed as a prescription drug under the trade name by Roche in most countries, and is sold over-the-counter as by GlaxoSmithKline in the United Kingdom and the United States.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.
The COA of Orlistat
| Items | Specifications | Result |
| Description | White to off white powder | Conforms |
| Identification | Similar to the standard | Conforms |
| Loss On Drying | 0.5% | 0.3% |
| Melting point | 70-74ºC | 71ºC |
| Heavy metal | ≤10ppm | 6.6ppm |
| Residue on ignition | ≤0.1% | 0.038% |
| Assay | ≥99.0% | 99.70% |
HNB Biotech company details
